In the US, there are about 50 million troponin, BNP, and other cardiac assays performed annually. At a price of $6 to 25 per test, this equates to a current market of $300 million to $1.25 billion. Moreover, if better biomarkers were available, market research suggests that an additional 6 ½ million acute and 42… Read More Qualitative Overview of Cardiac Biomarkers and Lab Services